Table 2.

Proinflammatory and proatherothrombotic markers at baseline

	Day 1 euglycemia	Day 2 hypoglycemia after day 1 euglycemia	Day 1 hypoglycemia	Day 2 hypoglycemia after day 1 hypoglycemia
ICAM (ng/mL)	90 ± 7	89 ± 7	88 ± 3	78 ± 5
VCAM (ng/mL)	838 ± 37	772 ± 43	819 ± 62	735 ± 48
E-selectin (ng/mL)	22 ± 2	18 ± 2	21 ± 2	16 ± 2
P-selectin (pg/mL)	83 ± 9	56 ± 6*	63 ± 13	45 ± 9*
PAI-1 (ng/mL)	18 ± 3	14 ± 2	13 ± 3	17 ± 6
TAT (ng/mL)	3.5 ± 0.4	2.9 ± 0.3	3.5 ± 0.2	3.6 ± 0.2
tPA (ng/mL)	6.1 ± 1	5.9 ± 1	5 ± 1	4.2 ± 1

Data are means ± SE.

*P < 0.05, significantly different from day 1 euglycemia at baseline.